The purpose of the Therapeutic Goods Advertising Consultative Committee (TGACC) is to provide a forum for engagement and consultation with industry, non-industry, and media bodies involved in the advertising of therapeutic goods to the public. The TGACC provides an opportunity for members to share their views on policy and operational performance issues relating to the therapeutic goods advertising regulatory framework and the way it is administered. This consultation mechanism supports continuous improvement of regulatory practices and assists in the development of education and compliance priorities to address non-compliance.
Type of Body
D. Advisory Body - Policy and Stakeholder Consultation
Established By / Under
Principal Body / Management Board / Senior Executive Officer
Annual Report Prepared and tabled?
PO Box 100 (MDP 122)
WODEN ACT 2606